Loading Density Influences the Tumor Cell Targeting and Signaling Inhibition Capabilities of Antibody Nanoconjugates

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Observational analysis shows that low antibody loading enhances targeting and signaling inhibition in TNBC, implying better therapeutic outcomes.

Lower antibody loading density of ∼60 antibodies per nanoconjugate significantly improved binding to TNBC cells.
The low-density FZD7-nanoshell conjugates exhibited ∼2× greater binding avidity to MDA-MB-231 cells than high-density counterparts.
Assessment using functional assays indicated that low-density conjugates led to greater inhibition of Wnt target genes as measured by RT-qPCR.
Significance calls for careful consideration of antibody loading density in the design of effective nanoparticle-based therapies.

Kramarenko et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Observational analysis shows that low antibody loading enhances targeting and signaling inhibition in TNBC, implying better therapeutic outcomes.

Lower antibody loading density of ∼60 antibodies per nanoconjugate significantly improved binding to TNBC cells.
The low-density FZD7-nanoshell conjugates exhibited ∼2× greater binding avidity to MDA-MB-231 cells than high-density counterparts.
Assessment using functional assays indicated that low-density conjugates led to greater inhibition of Wnt target genes as measured by RT-qPCR.
Significance calls for careful consideration of antibody loading density in the design of effective nanoparticle-based therapies.

Kramarenko et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark